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1. Introduction
Currently, there have been 
many studies on the supply of the 
human body with vitamin D (VD) 
and its biological role in the body.
It has been proven that VD 
functions are not limited to the 
control of calcium-phosphorus 
metabolism, but its other pleio-
tropic effects are being studied [1].
The active form of VD takes 
part in the regulation of cell dif-
ferentiation, proliferation, apop-
tosis, thereby inhibiting tumor 
growth; stimulates insulin syn-
thesis by β-cells of the pancreas 
and increases the sensitivity of 
human cells to insulin, regulates 
the function of T and B lympho-
cytes, macrophages, pro-inflam-
matory cytokines. The results of 
large-scale scientific studies of 
recent years indicate its import-
ant role in the development of the 
metabolic syndrome, endocrine 
disorders, including type 1 and 
type 2 diabetes, allergic, autoim-
mune, cardiovascular diseases in 
children.
Worldwide population studies 
have established that the preva-
lence of VD deficiency and hypo-
vitaminosis reaches an epidemic 
level. Thus, when examining the 
adult population of Ukraine, it 
was noted that only 4.6 % of res-
idents have a VD level within 
the normal range, 13.6 % have 
a deficiency, and 81.1 % have a 
VD hypovitaminosis. Population 
studies of the prevalence of VD 
hypovitaminosis in children in 
Ukraine have not been conduct-
ed, but according to some authors, 
its frequency is 88.5 % in children 
of school age [2].
Taking into account the 
above data, further study of the 
VD status in children of different 
ages and its pleiotropic effects is 
promising.
The aim of the research was 
to study the VD status and its 
possible effect on the lipid profile 
in children at risk for the devel-
opment of dyslipoproteinemia.
2. Methods
The study was conducted on the basis of the Centre of 
primary health care No. 4 of the city of Kiev during 2016– 
2017 years.
A total of 30 children aged 6–7 years old (mean age 6.4± 
±0.6 years) who were born to women with diabetes mellitus (DM) 
were examined comprehensively. As a control group, 30 chil- 
dren aged 6–7 years old (mean age 
6.5±0.5 years) were examined, who 
were born to healthy mothers.
Children’s anthropometric in- 
dicators (height, weight) were mea-
sured, the calculation of body mass 
index was done by the formula:
BMI=body weight, 
kg/square of height, m2.
Anthropometry was per-
formed by the standard meth-
od with an accuracy of 0.1 cm 
for growth and 0.1 kg for body 
weight. BMI (kg/m2) was estimat-
ed using percentile curves taking 
into account standard deviations 
(SD) for a certain age and sex 
[3]. Obesity in children was di-
agnosed with IMT>95 percentile 
(from +2 to +3 SD), overweight – 
with a BMI of 85–95 percentile 
(from + 1 to + 3 SD).
Children also were studied 
with lipid metabolism indi-
cators – total cholesterol (CS), 
triglycerides (TG), high density 
lipoprotein (HDL), low density 
lipoprotein (LDL), mmol/l in the 
blood by the enzymatic-colori-
metric method using RocheDiag-
nostics kits (Switzerland) on the 
analyzer Cobas 6000.
The atherogenic index (AI) 
was determined by an indirect 
calculation method according to 
the formula of A. N. Klimov:
IA=(CS–HDL)/HDL.
A qualitative assessment of 
the lipid profile was carried out 
according to the adapted NCEP/ 
ATPIII and ADF criteria.
In addition, the state of car-
bohydrate metabolism was as-
sessed by the level of glucose in 
the blood by the enzyme hexoki-
nase method.
The content of 25-OH-D in 
serum was determined by the 
ELISA kit 25-OH-VitaminD-ELI-
SA (BioVendor, Germany) ac-
cording to the instructions of the 
manufacturer.
The obtained data were processed on a personal computer 
using the statistical package Statistica 7 StatSoftInc. with the use 
of parametric and non-parametric estimation methods.
3. Results
In assessing the health status of children who were under 
observation, they took into account the family history data, 
information about the state of health, the severity of diabetes 
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in the mother and the degree of compensation of carbohydrate 
metabolism, as well as the features of the course of pregnancy 
and childbirth.
It is known that 16 (53.3 %) women suffered from type 
1 diabetes, 12 (40 %) – type 2, 2 (6.6 %) had gestational diabetes. 
Severe obstetric and gynecological anamnesis was detected in 
24 (80 %) women (spontaneous abortion, premature birth, in-
fertility, abortion for medical reasons, antenatal fetal death). All 
mothers of the examined children had diabetes combined with 
other chronic diseases — hypertension, chronic pancreatitis, 
cholecystitis, peptic ulcer. An analysis of the children’s develop-
mental histories showed that 20 (66.6 %) children were born by 
caesarean section, 23 (76.6 %) - in mild asphyxia, 5 (16.7 %) – 
moderate one; 4 (13.3 %) had respiratory distress syndrome on 
the background of lung atelectasis, 7 (23.3 %) children were born 
prematurely, all children showed signs of diabetic fetopathy, 
which is corresponds to the literature data on this issue [4, 5].
It should be noted that 80 % of the children we observed 
often had respiratory viral infections – 10 or more times 
throughout the year, had complications in the form of sinusitis, 
pneumonia, otitis. Most of the observed children were contin-
gent with nidus of chronic infection – chronic tonsillitis was 
diagnosed in 10 (33.3 %) children, adenoid vegetations of II-III 
degree – in 10 (33.3 %) children.
As shown by the results of clinical studies, among all dis-
eases in children who were born from mothers with diabetes, 
the pathology of the digestive system has a high proportion – so 
80 % of the observed children had dysfunction of the biliary 
system, 23.3 % had functional dyspepsia.
An assessment of the physical development of the observed 
children showed that 10 (33.3 %) children from mothers with 
diabetes are overweight, 5 (16.7 %) are obese. Moreover, 23.3 % 
of the mothers of the children surveyed were also obese, and in 
many children the immediate maternal relatives also had an over-
weight. It should be noted that in the control group the number 
of children with excess body weight was significantly less than 
in the group of children from mothers with diabetes (a total of 
5 children – 16.7 %), obesity was diagnosed in 2 children (6.6 %).
The state of carbohydrate metabolism in children from 
mothers with diabetes and in children of the control group was 
studied. The fasting glucose level in all the examined children 
from mothers with diabetes was within the range of physio-
logical fluctuations and did not differ from that in children of 
healthy mothers.
The study of the provision of VD showed that the level of 
its transport form 25-OH-D in children from mothers with 
diabetes, compared with the control group, was significantly re-
duced and amounted to 19.63 ng/ml (in children of healthy wo- 
men – 32.3 ng/ml). This indicates a marked deficiency of this ac-
tive metabolite of VD, its transport form in the body in children 
from mothers with diabetes.
It is possible that VD deficiency may be the result of nu-
tritional deficiency, which does not meet the increased needs 
of a growing organism, a decrease in its synthesis in the skin, 
metabolic disorders as a result of functional changes in target 
organs, connection disruptions of VD-receptor protein and the 
number of receptors to it [6].
In the study of lipid metabolism, there were significant im-
pairments in the group of children from mothers with diabetes 
(Table 1). Thus, according to our data, dyslipoproteinemia was 
detected in the observed children: a significant increase in se-
rum TG and cholesterol levels compared with the control group.
The analysis of the serum lipid spectrum showed that 
children from mothers with diabetes have higher LDL levels 
and lower HDL levels than in children from the control group 
(p<0.05). IA was significantly higher in the group of children 
from mothers with diabetes.
Table 1
Indicators of lipid metabolism in children 6–7 years old, who 
were born to mothers with diabetes (M±m)
Indicators Children of mothers with diabetes, n=30 Control group, n=30
Triglycerides, mmol/l 3.20±0.15* 1.90±0.12
Cholesterol, mmol/l 8.70±0.90* 5.10±0.80
HDL, mmol/l 1.48±0.11* 2.07±0.16
LDL, mmol/l 2.44±0.19* 1.46±0.13
IA,c.u. 4.8* 1.46
Note: the difference is significant (р<0.05)
4. Discussion
Thus, a study of the content of 25-OH-D in children of 
mothers with diabetes revealed its deficiency in blood serum 
compared with the control group.
The study of lipid metabolism showed an increase in the 
level of TG, cholesterol, LDL cholesterol, as well as a decrease in 
HDL cholesterol.
At present, the regulatory effect of VD on all metabolic 
processes in the body, including the synthesis of proteins, lipids, 
and cellular hormones, including insulin, is known. In addition, 
VD has a positive effect on the functional activity of a number 
of tissue enzymes and hormones by modifying the lipid compo-
sition of cellular and subcellular membranes [6].
In this regard, we believe that the revealed VD deficiency in 
the body of the examined children can be one of the causes of the 
dyslipidemia identified in them. According to the results of the 
research, children from mothers with diabetes were diagnosed 
with excess body weight 2 times more often than in the control, 
and obesity is 2.5 times more often - and this can also be a factor 
in the development of lipid metabolism disorders. According to 
the literature, obesity and overweight significantly increase the 
risk of dyslipidemia [7], more often in the form of a decrease in 
HDL cholesterol levels, which is the case in our patients.
It is known that dyslipidemia is accompanied by the depo-
sition of cholesterol, triglycerides in the vascular intima, as a 
result of which atheromatous plaques are formed. Atherogenic 
properties of LDL and apolipoprotein B. In contrast, HDL are 
involved in the so-called reverse cholesterol transport, taking it 
from the plasma membranes of the cells and transporting it to 
the liver. The final effect will depend on the ratio of these classes 
of lipoproteins, more precisely, on the ratio of cholesterol that is 
part of HDL and LDL ± the so-called IA. A high content of LDL 
cholesterol in serum with a low content of HDL cholesterol is an 
important factor in the development of atherosclerosis.
In our study, IA was significantly higher in the group of 
children from mothers with diabetes, which allows them to be 
included in the risk group.
A number of studies conducted in recent years demonstrate 
the association of VD levels with adverse changes in the lipid 
profile. A direct correlation was established between 25-OH-D 
values and HDL values, as well as a negative correlation with 
LDL and triglyceride levels [8]. Recent studies indicate that high 
levels of 25-OH-D are significant (p<0.05) lowering triglyceride 
levels and IA.
Pharmacotherapy of dyslipidemia is quite complicated. 
There are many drugs that reduce the level of cholesterol due 
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to the effect on different parts of its exchange. However, most 
of these drugs are not used in childhood due to numerous side 
effects. Given all the above, we believe that the use of VD for the 
correction of dyslipidemia in children is promising.
Currently, there are numerous researches in the world on 
the possibility of using VD as an adjuvant therapy for patients 
with hypercholesterolemia. In addition, it has been proven 
that VD regulates the immune inflammatory response in the 
vascular intima, which also allows its use for the prevention of 
atherosclerosis in risk groups.
It is well known that the presence of obesity, hyperlipidemia, 
arterial hypertension and disorders of carbohydrate metabolism 
are components of the metabolic syndrome in children, especially 
against the background of burdened heredity in type 2 diabetes. 
However, in the early stages of development, metabolic syn-
drome is asymptomatic, metabolic and functional changes are 
detected only during laboratory and instrumental examinations 
[9]. Therefore, an important task of family medicine is the early 
diagnosis of the preclinical stages of the metabolic syndrome by 
simple and accessible methods, especially among risk groups [10].
All things consider, research results indicate that:
1. Children who were born from mothers with diabetes may 
be considered at risk for the development of metabolic syn-
drome, atherosclerosis, diabetes.
2. One of the causes of the found violations may be a VD 
deficiency.
3. Children at risk need dynamic observation of anthropo-
metric indicators, control of body mass index, lipid and carbo-
hydrate blood profile, level 25-OH-D.
Prospects for further research are to explore the possibility 
of using VD for the primary prevention and treatment of meta-
bolic syndrome, diabetes in children.
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